Those drug-price negotiations, part of a Biden-era policy known as the Inflation Reduction Act, remain “top of mind” for the company with the new administration, Montarce said. Lilly Chief ...

Lilly’s first-quarter results were soft as it beat estimates for earnings but missed the same for sales. Strong demand for Mounjaro, Zepbound, Verzenio and Jardiance pulled the top line in the ...

Eli Lilly stock has advanced more than 200% over ... and that has kept them flying off pharmacy shelves. On top of this, analysts expect the weight loss drug market to soar from today's levels.